Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Other solid neoplasm 1CNS 1

Conditions

Mesothelioma, Malignant 10Solid Tumor, Adult 3Retinoblastoma 3Unspecified Adult Solid Tumor, Protocol Specific 2Solitary Fibrous Tumor, Pleural 2Solid Tumor 2Sarcoma 2Central Nervous System Neoplasms 2Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Solid Tumors 1Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) 1Postoperative Complications 1Pheochromocytoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroblastoma 1Metastatic Solid Tumors of Metastatic Disease 1Medulloblastoma 1Liver Neoplasms 1Head and Neck Neoplasms 1Head and Neck Carcinoma of Unknown Primary 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Familial ependymoma 1Ependymoma 1Choroid Plexus Neoplasms 1

Interventions

Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Postoperative Complications × Radiotherapy × Other solid neoplasm × Clear all
NCT00006231 2013-12-19

Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma

National Cancer Institute (NCI)

Phase 3 Completed
44 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡